Skip to content
Lower risk Drug recall · FDA · Published March 31, 2026

Avantor Magnesium Chloride API Recall: Subpotent Drug Risk

Avantor recalls bulk magnesium chloride API (NDC 10106-2448-1) due to subpotent drug risk. Affected lots may not meet required potency levels for pharmaceutical use.

🇺🇸 FDA recall #D-0488-2026DrugAvantor ›
Take action

Contact the company

Recalling firmAvantor Performance Materials LLC7001 Martin Luther King Jr Blvd · Paris, KY 40361-2147
✎ GovInfoNow plain-language explainer

What happened, in plain English

Avantor is recalling bulk magnesium chloride (6-hydrate) API products because they may not contain enough active ingredient. This could affect the effectiveness of medications if used in pharmaceutical manufacturing. Read more at govinfonow.com/recall/31382-avantor-magnesium-chloride-api-recall-subpotent-drug-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/31382-avantor-magnesium-chloride-api-recall-subpotent-drug-risk · Updated August 17, 2026 · FDA enforcement record: FDA #D-0488-2026

Cite this page

“Avantor Magnesium Chloride API Recall: Subpotent Drug Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31382-avantor-magnesium-chloride-api-recall-subpotent-drug-risk. Based on FDA recall #D-0488-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0488-2026%22&limit=1).

Why it’s dangerous

The magnesium chloride API may have lower-than-stated potency levels. This means it might not provide the required amount of active ingredient for drug formulations, potentially leading to ineffective medications.

Who’s affected

Pharmaceutical manufacturers using this magnesium chloride API for drug production are likely affected. Those handling the product without proper quality checks may be at risk of ineffective medications.

How to tell if you have this one

Check for NDC 10106-2448-1 on the product label. The product was manufactured in Lot 23G3161005 and expires September 21, 2027.

  • Brand
    Avantor
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Label

    Look for NDC 10106-2448-1 and Lot 23G3161005 on the product label.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA, Belgium and France” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA published this recall 22 days after the firm started it.

1. Firm started the recall: Mar 31, 202612. FDA classified it Class III: Apr 22, 202623. Published in FDA’s Enforcement Report: Apr 22, 202632026
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Is this product safe to use?

The recall is for pharmaceutical manufacturing use only. This product is not intended for human consumption and is safe for its intended use when properly tested.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0488-2026 (March 31, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0488-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA